Abbott (NYSE: ABT) awards director 2,286 restricted stock units

robot
Abstract generation in progress

Abbott Laboratories director Kevin T. Conroy was granted 2,286 restricted stock units under the company’s 2026 Incentive Stock Program. This award is compensation, not an open-market purchase, and will be settled in Abbott common shares upon conditions such as separation from service, death, or a change in control. Following this grant, Conroy directly holds 133,737 Abbott common shares.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments